Texture analysis, with optical coherence tomography scans and electroretinograms, can identify retinal changes during early stages of T2D.

The FDA approved Lerochol, a monthly PCSK9 inhibitor, for adults with hypercholesterolemia to reduce LDL-C levels alongside diet and exercise.

A data monitoring committee recommended stopping the phase 3 trials of efgartigimod in thyroid eye disease due to lack of efficacy.

“Consistent with prior work, we observed low adherence (7.3 percent) to cervical cancer screening guidelines among the commercially insured U.S. population despite stable coverage, likely reflecting ...

A rapid, user-friendly, highly accurate sensitive molecular test has been developed for diagnosing hepatitis C virus (HCV).

Giredestrant shows significant improvement in iDFS in patients with early-stage, HR-positive, HER2-negative breast cancer.

The U.S. Centers for Disease Control and Prevention (CDC) reported that COVID vaccines reduced the risk of ER visits by 76% in kids under age 4 and by 56% in kids ages 5 to 17 during the first six ...

Atezolizumab plus standard therapy was not associated with improved survival in advanced recurrent ovarian cancer.

Mental health diseases are associated with an increased risk for developing hepatocellular carcinoma (HCC) among veterans with cirrhosis.

Integrating methadone treatment into primary care settings improves adherence to guideline-concordant health care for opioid use disorder.

Use of menopausal hormone therapy following menopause is not associated with increased risk for breast cancer among BRCA1 and BRCA2 carriers.

The FDA has expanded the approval of Addyi to include the treatment of hypoactive sexual desire disorder in women less than 65 years.